Skip to main content

Table 3 Effects of CPCM on lipid metabolism, liver weight and liver index in db/db mice

From: The beneficial effects of the composite probiotics from camel milk on glucose and lipid metabolism, liver and renal function and gut microbiota in db/db mice

 

Normal (n=10)

Model (n=9)

Metoformin (n=10)

Low dose (n=10)

High dose (n=10)

Triglyceride (mmol/L)

0.92±0.21

3.47±0.73***

1.75±0.52###

1.76±0.48###

1.68±0.30###

Total cholesterol (mmol/L)

2.92±0.36

5.24±0.63***

4.31±0.48#

4.24±0.62#

4.44±0.44#

High density lipoprotein-cholesterol (mmol/L)

0.08±0.02

0.09±0.03

0.12±0.04

0.11±0.03

0.10±0.02

Low density lipoprotein-cholesterol (mmol/L)

1.63±0.22

3.10±0.32***

2.58±0.31#

2.61±0.32#

2.68±0.25#

Liver wet weight (g)

0.91±0.16

2.80±0.46***

2.67±0.38

2.53±0.37

2.82±0.76

Liver index (102)

3.96±0.21

5.97±0.56***

5.15±0.66#

5.20±0.78

5.14±0.53#

  1. ***P <0.001 vs normal group; # P <0.05 and ### P <0.001 vs model group